Since ArthroCare® Spine received U.S. Food and Drug Administration (FDA) clearance in 1999 for it's first spine system, we have been advancing the science of treating spine-related conditions by pioneering minimally invasive procedures for spinal surgery. Worldwide, over 100,000 Nucleoplasty procedures have been performed since the year 2000. This minimally invasive approach to treating contained disc herniations has helped over 100,000 patients return to active and productive lives.